{ "labelLang" : "hun", "responseDate" : "2024-03-29 11:39", "content" : { "otype" : "JournalArticle", "mtid" : 23616652, "status" : "ADMIN_APPROVED", "published" : true, "comment" : "Cited By :9 \n Export Date: 21 March 2024 \n Correspondence Address: Canda, A.E.321 Sok. 16 Güzelbahçe, 35310 Izmir, Turkey; email: erdemcanda@yahoo.com", "unhandledTickets" : 0, "oldTimestamp" : "2018-10-01T21:56:42.000+0000", "deleted" : false, "oldId" : 13616652, "lastRefresh" : "2024-03-21T08:35:22.690+0000", "lastModified" : "2018-10-01T21:56:42.000+0000", "created" : "2014-01-27T11:02:42.000+0000", "creator" : { "otype" : "Author", "mtid" : 10001047, "link" : "/api/author/10001047", "label" : "Szolcsányi János (Farmakológia)", "familyName" : "Szolcsányi", "givenName" : "János", "published" : true, "oldId" : 10001047, "snippet" : true }, "lastDuplumSearch" : "2024-03-21T08:24:23.781+0000", "adminApproved" : "2017-06-01T05:18:20.000+0000", "adminApprover" : { "otype" : "Admin", "mtid" : 10022754, "link" : "/api/admin/10022754", "label" : "Milánkovics Róbert (PTE ÁOK admin 5)", "familyName" : "Milánkovics", "givenName" : "Róbert", "published" : true, "oldId" : 10022754, "snippet" : true }, "core" : false, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Canda, AE", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 31877478, "link" : "/api/authorship/31877478", "label" : "Canda, AE", "listPosition" : 1, "share" : 0.0, "first" : true, "last" : false, "familyName" : "Canda", "givenName" : "AE", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 51305720, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 31877479, "link" : "/api/authorship/31877479", "label" : "Cross, RL", "listPosition" : 2, "share" : 0.0, "first" : false, "last" : false, "familyName" : "Cross", "givenName" : "RL", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 51305719, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 31877480, "link" : "/api/authorship/31877480", "label" : "Chapple, CR", "listPosition" : 3, "share" : 0.0, "first" : false, "last" : true, "familyName" : "Chapple", "givenName" : "CR", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "oldId" : 51305718, "snippet" : true } ], "title" : "Pharmacology of the lower urinary tract and management of overactive bladder", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 7150982, "link" : "/api/publicationidentifier/7150982", "label" : "Scopus: 33746275235", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "33746275235", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-33746275235", "published" : false, "oldId" : 4949401, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 10012244, "link" : "/api/journal/10012244", "label" : "JOURNAL OF TURKISH-GERMAN GYNAECOLOGICAL ASSOCIATION 1309-0399 1309-0380", "pIssn" : "1309-0399", "eIssn" : "1309-0380", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 10012244, "snippet" : true }, "volume" : "7", "issue" : "2", "firstPage" : "146", "lastPage" : "157", "firstPageOrInternalIdForSort" : "146", "pageLength" : 12, "publishedYear" : 2006, "digital" : null, "printed" : null, "sourceYear" : 2014, "packet" : "661513", "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : false, "conferencePublication" : null, "nationalOrigin" : null, "missingAuthor" : false, "oaType" : "GOLD", "oaCheckDate" : "2024-03-21", "oaFree" : false, "oaLink" : "http://www.jtgga.org", "citationCount" : 0, "citationCountUnpublished" : 0, "citationCountWoOther" : 0, "independentCitCountWoOther" : 0, "doiCitationCount" : 0, "wosCitationCount" : 0, "scopusCitationCount" : 0, "independentCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 0, "independentCitingPubCount" : 0, "unhandledCitingPubCount" : 0, "citedPubCount" : 2, "citedCount" : 2, "referenceList" : "Andersson, K.E., Arner, A., Urinary bladder contraction and relaxation: Physiology and pathophysiology (2004) Physiol Rev, 84 (3), pp. 935-986; \n\nChess-Williams, R., Muscarinic receptors of the urinary bladder: Detrusor, urothelial and prejunctional (2002) Auton Autacoid Pharmacol, 22 (3), pp. 133-145; \n\nNagahama, K., Tsujii, T., Morita, T., Differences between proximal and distal portions of the male rabbit posterior urethra in the physiological role of muscarinic cholinergic receptors (1998) Br J Pharmacol, 124, pp. 1175-1180; \n\nBurnstock, G., Purinergic signalling in lower urinary tract (2001) Purinergic and Pyrimidinergic Signalling I: Molecular, Nervous and Urogenitary System Function, pp. 421-515. , Ch. 15 (Eds M.P. Abbracchio & M. Williams), Springer-Verlag, Berlin Heidelberg; \n\nChancellor, M.B., Kaplan, S.A., Blaivas, J.G., The cholinergic and purinergic components of detrusor contractility in a whole rabbit bladder model (1992) J Urol, 148, pp. 906-909; \n\nTheobald, R.J., Purinergic and cholinergic components of bladder contactility and now (1995) Life Sci, 56, pp. 445-454; \n\nAbrams, P., Cardozo, L., Fall, M., The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society (2002) Neurourol Urodyn, 21, pp. 167-178; \n\nMilsom, I., Abrams, P., Cardozo, L., How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study (2001) BJU Int, 87, pp. 760-766; \n\nChapple, C.R., Yamanishi, T., Chess-Williams, R., Muscarinic receptor subtypes and management of the overactive bladder (2002) Urology, 60 (5 SUPPL. 1), pp. 82-89; \n\nWang, P., Luthin, G.R., Ruggieri, M.R., Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins (1995) J Pharmacol Exp Ther, 273, pp. 959-966; \n\nYamanishi, T., Chapple, C.R., Yasuda, K., Chess-Williams, R., The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro (2000) Br J Pharmacol, 131 (7), pp. 1482-1488; \n\nChess-Williams, R., Chapple, C.R., Yamanishi, T., The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro (2001) J Auton Pharmacol, 21 (5-6), pp. 243-248; \n\nD'Agostino, G., Bolognesi, M.L., Lucchelli, A., Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: Involvement of the M4 receptor subtype (2000) Br J Pharmacol, 129, pp. 493-500; \n\nLevin, R.M., Ruggieri, M.R., Wein, A.J., Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding (1998) J Urol, 139, pp. 844-848; \n\nMimata, H., Wheeler, M.A., Fukumoto, Y., Enhancement of muscarinic receptor-coupled phosphatidylinositol hydrolysis in diabetic bladder (1995) Mol Cell Biochem, 152, pp. 71-76; \n\nCaulfield, M.P., Birdsall, N.J.M., International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors (1998) Pharmacol Rev, 50, pp. 279-290; \n\nAndersson, K.E., Holmquist, F., Fovaeus, M., Muscarinic receptor stimulation of phosphoinositide hydrolysis in the human isolated urinary bladder (1991) J Urol, 146, pp. 1156-1159; \n\nChambers, P., Neal, D.E., Gillespie, J.I., Ca 2+ signalling in cultured smooth muscle cells from human bladder (1996) Exp Physiol, 81, pp. 553-564; \n\nVisser, A.J., Van Mastrigt, R., The role of intracellular and extracellular calcium in mechanical and intracellular electrical activity of human urinary bladder smooth muscle (2000) Urol Res, 28, pp. 260-268; \n\nJezior, J.R., Brady, J.D., Rosentein, D.I., Dependency of detrusor contraction on calcium sensitisation and calcium entry through LOE-908-sensitive channels (2001) Br J Pharmacol, 134, pp. 78-87; \n\nHarriss, D.R., Marsh, K.A., Birmingham, A.T., Hill, S.J., Expression of muscarinic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells (1995) J Urol, 154, pp. 1241-1245; \n\nEglen, R.M., Hegde, S.S., Watson, N., Muscarinic receptor subtypes and smooth muscle function (1996) Pharmacol Rev, 15, pp. 114-119; \n\nYamanishi, T., Yasuda, K., Chapple, C.R., Chess-Williams, R., The role of M2-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro (2000) Br J Pharmacol, 131 (7), pp. 1482-1488; \n\nHypolite, J.A., Longhurst, P.A., Gong, C., Metabolic studies on rabbit bladder smooth muscle and mucosal epithelium (1993) Mol Cell Biochem, 125, pp. 35-42; \n\nHawthorn, M.H., Chapple, C.R., Cock, M., Chess-Williams, R., Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro (2000) Br J Pharmacol, 129 (3), pp. 416-419; \n\nWayabayashi, Y., Kojima, Y., Makiura, Y., Acetylcholinesterase positive axons in the mucosa of urinary bladder of adult cats: Retrograde tracing and degeneration studies (1995) Histol Histopathol, 10, pp. 523-530; \n\nTempleman, L., Chapple, C.R., Chess-Williams, R., Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig (2002) J Urol, 167 (2 PART 1), pp. 742-745; \n\nChaiyaprasithi, B., Mang, C.F., Kilbinger, H., Hohenfellner, M., Inhibition of human detrusor contraction by a urothelium derived factor (2003) J Urol, 170 (5), pp. 1897-1900; \n\nNomiya, M., Yamaguchi, O., A quantitative analysis of mRNA expression of α1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders (2003) J Urol, 170, pp. 649-653; \n\nAndersson, K.E., Wein, A.J., Pharmacology of the lower urinary tract: Basis for current and future treatments of urinary incontinence (2004) Pharmacol Rev, 56 (4), pp. 581-631; \n\nMorita, T., Iizuka, H., Iwata, T., Kondo, S., Function and distribution of β3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter (2000) J Smooth Muscle Res, 36, pp. 21-32; \n\nAndersson, K.E., Pharmacology of lower urinary tract smooth muscles and penile erectile tissues (1993) Pharmacol Rev, 45, pp. 253-308; \n\nRestorick, J.M., Mundy, A.R., The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyperreflexic human detrusor (1989) Br J Urol, 63, pp. 32-35; \n\nMalloy, B.J., Price, D.T., Price, R.R., Alpha1-adrenergic receptor subtypes in human detrusor (1998) J Urol, 160, pp. 937-943; \n\nSmith, D.J., Chapple, C.R., In vitro response of human bladder smooth muscle in unstable obstructed male bladders: A study of pathophysiological causes? (1994) Neurourol Urodyn, 34, pp. 14-15; \n\nSjogren, C., Andersson, K.E., Husted, S., Atropine resistance of transmurally stimulated isolated human bladder muscle (1982) J Urol, 128, pp. 1368-1371; \n\nKlein, L.A., Urge incontinence can be a disease of bladder sensors (1988) J Urol, 139, pp. 1010-1014; \n\nAndersson, K.E., Bladder activation: Afferent mechanisms (2002) Urology, 59 (SUPPL. 5A), pp. 43-50; \n\nWakabayashi, Y., Tomoyoshi, T., Fujimiya, M., Substance P-containing axon terminals in the mucosa of the human urinary bladder: Pre-embedding immunohistochemistry using cryostat sections for electron microscopy (1993) Histochemistry, 100, pp. 401-407; \n\nMaggi, C.A., Tachykinins and calcitonin gene-related peptide (CGRP) as cotransmitters released from peripheral endings of sensory nerves (1995) Prog Neurobiol, 45, pp. 1-98; \n\nKumar, V., Chapple, C.R., Chess-Williams, R., Characteristics of adenosine triphosphatase release from porcine and human normal bladder (2004) J Urol, 172 (2), pp. 744-747; \n\nBurnstock, G., Williams, M., P2 purinergic receptors: Modulation of cell function and therapeutic potential (2000) J Pharmacol Exp Ther, 295, pp. 862-869; \n\nDixon, J.S., Gilpin, C.J., Presumptive sensory axons of the human urinary bladder: A fine structural study (1987) J Anat, 151, pp. 199-207; \n\nO'Reilly, B.A., Kosaka, A.H., Chang, T.K., A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction (2001) BJU Int, 87, pp. 617-622; \n\nElneil, S., Skepper, J.N., Kidd, E.J., Distribution of P2X(1) and P2X(3) receptors in the rat and human urinary bladder (2001) Pharmacology, 63 (2), pp. 120-128; \n\nAndersson, K.E., Hedund, P., Pharmacologic perspective on the physiology of the lower urinary tract (2002) Urology, 60 (SUPPL. 5A), pp. 13-21; \n\nAbbracchio, M.P., Boarder, M., Burnstock, G., Purinergic signaling in lower urinary tract (2001) Purinergic and Pyrimidine Signaling I: Molecular, Nervous and Urogenitary System Function, pp. 423-515. , Edited by M. P. Abbracchio and M. Williams. Berlin: Springer; \n\nHarvey, R.A., Skennerton, D.E., Newgreen, D., Fry, C.H., The contractile potency of adenosine triphosphate and ecto-adenosine triphosphatase activity in guinea pig detrusor and detrusor from patients with a stable, unstable or obstructed bladder (2002) J Urol, 168, pp. 1235-1239; \n\nO'Reilly, B.A., Kosaka, A.H., Knight, G.F., P2X receptors and their role in female idiopathic detrusor instability (2002) J Urol, 167, pp. 157-164; \n\nMoore, K.H., Ray, F.R., Barden, J.A., Loss of purinergic P2X(3) and P2X(5) receptor innervation in human detrusor from adults with urge incontinence (2001) J Neurosci, 21 (18), pp. RC166; \n\nAndersson, K.E., Persson, K., The L-arginine/nitric oxide pathway and nonadrenergic, non-cholinergic relaxation of the lower urinary tract (1993) Gen Pharmacol, 24, pp. 833-839; \n\nEhren, I., Iversen, H., Jansson, O., Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses (1994) Urology, 44, pp. 683-687; \n\nMasuda, H., Tsujii, T., Okuno, T., Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract (2002) J Urol, 167, pp. 2235-2240; \n\nLemack, G.E., Zimmern, P.E., Vazquez, D., Altered response to partial bladder outlet obstruction in mice lacking inducible nitric oxide synthase (2000) J Urol, 163, pp. 1981-1987; \n\nJames, M.J., Birmingham, A.T., Hill, S.J., Partial mediation by nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation (1993) Br J Clin Pharmacol, 35, pp. 366-372; \n\nHofmann, F., Ammendola, A., Schlossmann, J., Rising behind NO: CGMP-dependent protein kinases (2000) J Cell Sci, 113, pp. 1671-1676; \n\nKlarskov, P., Non-cholinergic, non-adrenergic inhibitory nerve responses of bladder outlet smooth muscle in vitro (1987) Br J Urol, 60, pp. 337-342; \n\nCoolsaet, B.L., Bladder compliance and detrusor activity during the collection phase (1985) Neurourol Urodyn, 4, pp. 263-273; \n\nKlevmark, B., Motility of the urinary bladder in cats during filling at physiological rates. II. Effects of extrinsic bladder denervation on intramural tension and on intravesical pressure patterns (1977) Acta Physiol Scand, 101, pp. 176-184; \n\nDe Groat, W.C., Nervous control of the urinary bladder of the cat (1975) Brain Res, 87, pp. 201-211; \n\nTheobald Jr., R.J., The effect of NG-monomethyl-L-arginine on bladder function (1996) Eur J Pharmacol, 311, pp. 73-78; \n\nKlarskov, P., Hørby-Petersen, J., Infuence of serotonin on lower urinary tract smooth muscle in vitro (1986) Br J Urol, 58, pp. 507-513; \n\nTonini, M., Messori, E., Franceschetti, G.P., Characterization of the 5-HT receptor potentiating neuromuscular cholinergic transmission in strips of human isolated detrusor muscle (1994) Br J Pharmacol, 113, pp. 1-2; \n\nSzallasi, A., Blumberg, P.M., Vanilloid (capsaicin) receptors and mechanisms (1999) Pharmacol Rev, 51, pp. 159-211; \n\nHayes, P., Meadows, J., Gunthorpe, M.J., Cloning and functional expression of a human orthologue of rat vanilloid receptor-1 (2000) Pain, 88 (2), pp. 205-215; \n\nYiangou, Y., Facer, P., Ford, A., Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder (2001) BJU Int, 87 (9), pp. 774-779; \n\nBirder, L.A., Kanai, A.J., De Groat, W.C., Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells (2001) Proc Natl Acad Sci U S A, 98, pp. 13396-13401; \n\nCruz, F., Mechanisms involved in new therapies for overactive bladder (2004) Urology, 63 (SUPPL. 3A), pp. 65-73; \n\nCaterina, M.J., Schumacher, M.A., Tominaga, M., The capsaicin receptor: A heat-activated ion channel in the pain pathway (1997) Nature, 389, pp. 816-824; \n\nCaterina, M.J., Leffler, A., Malmberg, A.B., Impaired nociception and pain sensation in mice lacking the capsaicin receptor (2000) Science, 288, pp. 306-313; \n\nTominaga, M., Caterina, M.J., Malmberg, A.B., The cloned capsaicin receptor integrates multiple pain-producing stimuli (1998) Neuron, 21 (3), pp. 531-543; \n\nDe Ridder, D., Chandiramani, V., Dasgupta, P., Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: A dual center study with long-term followup (1997) J Urol, 158 (6), pp. 2087-2092; \n\nGiannantoni, A., Di Stasi, S.M., Stephen, R.L., Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: A prospective randomized study (2002) J Urol, 167 (4), pp. 1710-1714; \n\nAvelino, A., Cruz, C., Cruz, F., Nerve growth factor regulates galanin and c-jun overexpression occurring in dorsal root ganglion cells after intravesical resiniferatoxin application (2002) Brain Res, 951, pp. 264-269; \n\nSzoke, E., Seress, L., Szolcsanyi, J., Neonatal capsaicin treatment results in prolonged mitochondrial damage and delayed cell death of B cells in the rat trigeminal ganglia (2002) Neuroscience, 113, pp. 925-937; \n\nHabler, H.J., Jänig, W., Koltzenburg, M., Activation of unmyelinated afferent fibers by mechanical stimuli and inflammation of the urinary bladder in the cat (1990) J Physiol (Lond), 425, pp. 545-562; \n\nDe Groat, W.C., A neurologic basis for the overactive bladder (1997) Urology, 50 (SUPPL. 6A), pp. 36-52; \n\nJankovic, J., Brin, M.F., Botulinum toxin: Historical perspective and potential new indications (1997) Muscle Nerve, 6 (SUPPL.), pp. 129-145; \n\nSchurch, B., Stöhrer, M., Kramer, G., Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results (2000) J Urol, 164, pp. 692-697; \n\nKhan, M.A., Thompson, C.S., Mumtaz, F.H., Role of prostaglandins in the urinary bladder: An update (1998) Prostaglandins Leukot Essent Fatty Acids, 59, pp. 415-422; \n\nGilmore, N.J., Vane, J.R., Hormones released into the circulation when the urinary bladder of the anaesthetized dog is distended (1971) Clin Sci, 41, pp. 69-83; \n\nAndersson, K.E., Sjogren, C., Aspects on the physiology and pharmacology of the bladder and urethra (1982) Prog Neurobiol, 19, pp. 71-89; \n\nBouchelouche, K., Andersen, L., Nordling, J., The cysteinyl-leukotriene D4 induces cytosolic Ca 2+ elevation and contraction of the human detrusor muscle (2003) J Urol, 170, pp. 638-644; \n\nSjogren, C., Andersson, K.E., Mattiasson, A., Effects of vasoactive intestinal polypeptide on isolated urethral and urinary bladder smooth muscle from rabbit and man (1985) J Urol, 133, pp. 136-140; \n\nUckert, S., Stief, C.G., Lietz, B., Possible role of bioactive peptides in the regulation of human detrusor smooth muscle (2002) World J Urol, 20, pp. 244-249; \n\nChapple, C.R., Milner, P., Moss, H.E., Burnstock, G., Loss of sensory neuropeptides in the obstructed human bladder (1992) Br J Urol, 70, pp. 373-381; \n\nGu, J., Restorick, J.M., Blank, M.A., Vasoactive intestinal polypeptide in the normal and unstable bladder (1983) Br J Urol, 55, pp. 645-647; \n\nGarcia-Pascual, A., Persson, K., Holmquist, F., Andersson, K.E., Endothelin-1-induced phosphoinositide hydrolysis and contraction in isolated rabbit detrusor and urethral smooth muscle (1993) Gen Pharmacol, 24, pp. 131-138; \n\nLecci, A., Maggi, C.A., Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system (2001) Regul Pept, 101, pp. 1-18; \n\nMaggi, C.A., Patacchini, R., Santicioli, P., Further studies on the motor response of the human isolated urinary bladder to tachykinins, capsaicin and electrical field stimulation (1989) Gen Pharmacol, 20, pp. 663-669; \n\nWaldeck, K., Lindberg, B.F., Persson, K., Andersson, K.E., Characterization of angiotensin II formation in human isolated bladder by selective inhibitors of ACE and human chymase: A functional and biochemical study (1997) Br J Pharmacol, 121, pp. 1081-1086; \n\nLam, D.S., Dias, L.S., Moore, K.H., Burcher, E., Angiotensin II in child urinary bladder: Functional and autoradiographic studies (2000) BJU Int, 86, pp. 494-501; \n\nDrake, M.J., Headlund, P., Harvey, I.J., Partial outlet obstruction enhances modular autonomous activity in the isolated rat bladder (2003) Journal of Urology, 170, pp. 276-279; \n\nFry, C.H., Sui, G.P., Severs, N.J., Wu, C., Spontaneous activity and electrical coupling in human detrusor smooth muscle: Implications for detrusor overactivity? (2004) Urology, 63 (3 SUPPL. 1), pp. 3-10; \n\nMontgomery, B.S., Fry, C.H., The action potential and net membrane currents in isolated human detrusor smooth muscle cells (1992) J Urol, 147 (1), pp. 176-184; \n\nHashitani, H., Brading, A.F., Suzuki, H., Correlation between spontaneous electrical, calcium and mechanical activity in detrusor smooth muscle of the guinea-pig bladder (2004) Br J Pharmacol, 141 (1), pp. 183-193; \n\nSanders, K.M., A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract (1996) Gastroenterology, 111 (2), pp. 492-515; \n\nHirst, G.D., Ward, S.M., Interstitial cells: Involvement in rhythmicity and neural control of gut smooth muscle (2003) J Physiol, 550 (PART 2), pp. 337-346; \n\nSmet, P.J., Jonavicius, J., Marshall, V.R., De Vente, J., Distribution of nitric oxide synthase-immunoreactive nerves and identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry (1996) Neuroscience, 71 (2), pp. 337-348; \n\nMcCloskey, K.D., Gurney, A.M., Kit positive cells in the guinea pig bladder (2002) J Urol, 168 (2), pp. 832-836; \n\nSergeant, G.P., Hollywood, M.A., McCloskey, K.D., Specialised pacemaking cells in the rabbit urethra (2000) J Physiol, 526 (PART 2), pp. 359-366; \n\nGillespie, J.I., Markerink-Van Ittersum, M., De Vente, J., cGMP-generating cells in the bladder wall: Identification of distinct networks of interstitial cells (2004) BJU Int, 94 (7), pp. 1114-1124; \n\nHashitani, H., Yanai, Y., Suzuki, H., Role of interstitial cells and gap junctions in the transmission of spontaneous Ca 2+ signals in detrusor smooth muscles of the guinea-pig urinary' bladder (2004) J Physiol, 559 (PART 2), pp. 567-581; \n\nSui, G.P., Wu, C., Fry, C.H., Electrical characteristics of suburothelial cells isolated from the human bladder (2004) J Urol, 171 (2 PART 1), pp. 938-943; \n\nSui, G.P., Rothery, S., Dupont, E., Fry, C.H., Severs, N.J., Gap junctions and connexin expression in human suburothelial interstitial cells (2002) BJU Int, 90 (1), pp. 118-129; \n\nFerguson, D.R., Kennedy, I., Burton, T.J., ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - A possible sensory mechanism? (1997) J Physiol, 505 (PART 2), pp. 503-511; \n\nGillespie, J.I., The autonomous bladder: A view of the origin of bladder overactivity and sensory urge (2004) BJU Int, 93 (4), pp. 478-483; \n\nGillespie, J., Harvey, I., Drake, M., Agonist and nerve-induced phasic activity in the isolated whole bladder of the guinea pig: Evidence for two types of bladder activity (2003) Exp Physiol, 88, pp. 343-357; \n\nGillespie, J.I., Noradrenaline inhibits autonomous activity in the isolated guinea pig bladder (2004) BJU Int, 93, pp. 401-409; \n\nGillespie, J., Inhibitory actions of calcitonin gene-related peptide and capsaicin: Evidence for local axonal reflexes in the bladder wall (2005) BJU Int, 95, pp. 149-156; \n\nGillespie, J.I., Phosphodiesterase-linked inhibition of nonmicturition activity in the isolated bladder (2004) BJU Int, 93, pp. 1325-1332; \n\nGillespie, J.I., Drake, M.J., The actions of sodium nitroprusside and the phosphodiesterase inhibitor dipyridamole on phasic activity in the isolated guinea-pig bladder (2004) BJU Int, 93, pp. 851-858; \n\nGillespie, J.I., Modulation of autonomous contractile activity in the isolated whole bladder of the guinea pig (2004) BJU Int, 93, pp. 393-400; \n\nGillespie, J., Inhibitory actions of calcitonin gene-related peptide and capsaicin: Evidence for local axonal reflexes in the bladder wall (2005) BJU Int, 95, pp. 149-156; \n\nLagou, M., Drake, M.J., Gillespie, J.I., Volume-induced effects on the isolated bladder: A possible local reflex (2004) BJU Int, 94, pp. 1356-1365; \n\nKubota, Y., Kajioka, S., Biers, S.M., Investigation of the effect of the c-kit inhibitor Glivec on isolated guinea-pig detrusor preparations (2004) Autonomic Neuroscience, 115, pp. 64-73; \n\nRovner, E.S., Wein, A.J., Incidence and prevalence of overactive bladder (2002) Curr Urol Rep, 3, pp. 434-438; \n\nWein, A.J., Diagnosis and treatment of the overactive bladder (2003) Urology, 62 (SUPPL. 5B), pp. 20-27; \n\nFantl, J.A., Wyman, J.F., McClish, D.K., Efficacy of bladder training in older women with urinary incontinence (1991) JAMA, 265 (5), pp. 609-613; \n\nAndersson, K.E., Treatment of the overactive bladder: Possible central nervous system drug targets (2002) Urology, 59 (SUPPL. 1), pp. 18-24; \n\nKachur, J.F., Peterson, J.S., Carter, J.P., R and S enantiomers of oxybutynin: Pharmacological effects in guinea pig bladder and intestine (1988) J Pharmacol Exp Ther, 247 (3), pp. 867-872; \n\nNilvebrant, L., Andersson, K.E., Gillberg, P.G., Tolterodine: A new bladder selective antimuscarinic agent (1997) Eur J Pharmacol, 327, pp. 195-207; \n\nWaldeck, K., Larsson, B., Andersson, K.E., Comparison of oxybutynin and its active metabolite, N-desethyl- oxybutynin, in the human detrusor and parotid gland (1997) J Urol, 157, pp. 1093-1097; \n\nBirns, J., Lukkari, E., Malone Lee, J.G., A randomized controlled trial comparing the efficacy of controlled-release oxybutynin tablets (10 mg once daily) with conventional oxybutynin tablets (5 mg twice daily) in patients whose symptoms were stabilized on 5 mg twice daily of oxybutynin (2000) BJU Int, 85, pp. 793-798; \n\nAppell, R.A., Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis (1997) Urology, 50 (SUPPL.), pp. 90-96; \n\nDrutz, H., Appell, R.A., Gleason, D., Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder (1999) Int Urogynecol J Pelvic Floor Dysfunct, 10 (5), pp. 283-289; \n\nKobelt, G., Jönsson, L., Mattiasson, A., Cost-effectiveness of new treatments for overactive bladder: The example of tolterodine, a new muscarinic agent: A Markov model (1998) Neurourol Urodyn, 17, pp. 599-611; \n\nChapple, C.R., Nilvebrant, L., Tolterodine: Selectivity for the urinary bladder over the eye (as measured by visual accommodation) in healthy volunteers (2002) Drugs RD, 3 (2), pp. 75-81; \n\nChapple, C.R., Rechberger, T., Al-Shukri, S., Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder (2004) BJU Int, 93 (3), pp. 303-310; \n\nChapple, C.R., Martinez-Garcia, R., Selvaggi, L., A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: Results of the STAR trial (2005) Eur Urol, 48 (3), pp. 464-470; \n\nKelleher, C.J., Cardozo, L., Chapple, C.R., Improved quality of life in patients with overactive bladder symptoms treated with solifenacin (2005) BJU Int, 95 (1), pp. 81-85; \n\nGillberg, P.G., Sundquist, S., Nilvebrant, L., Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists (1998) Eur J Pharmacol, 349, pp. 285-292; \n\nNewgreen, D.T., Anderson, C.W.P., Carter, A.J., Darifenacin: A novel bladder-selective agent for the treatment of urge incontinence (1995) Neurourol Urodyn, 14, pp. 555-557; \n\nWallis, R.M., Napier, C.M., Muscarinic antagonists in development for disorders of smooth muscle function (1999) Life Sci, 64, pp. 395-401; \n\nChapple, C., Steers, W., Norton, P., A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder (2005) BJU Int, 95 (7), pp. 993-1001; \n\nChapple, C.R., Abrams, P., Comparison of darifenacin and oxybutynin in patients with overactive bladder: Assessment of ambulatory urodynamics and impact on salivary flow (2005) Eur Urol, 48 (1), pp. 102-109; \n\nGunnarsson, M., Teleman, P., Mattiasson, A., Effects of pelvic floor exercises in middle aged women with a history of naive urinary incontinence: A population based study (2002) Eur Urol, 41 (5), pp. 556-561; \n\nBerghmans, B., Van Waalwijk Van Doom, E., Nieman, F., Efficacy of physical therapeutic modalities in women with proven bladder overactivity (2002) Eur Urol, 41 (6), pp. 581-587; \n\nKalsi, V., Apostolidis, A., Popat, R., Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type a and correlations with lower urinary tract symptoms and urodynamic changes (2006) Eur Urol, 49 (3), pp. 528-535; \n\nReitz, A., Stohrer, M., Kramer, G., European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity (2004) Eur Urol, 45 (4), pp. 510-515; \n\nSilva, C., Silva, J., Ribeiro, M.J., Avelino, A., Cruz, F., Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: Results of a double-blind randomized placebo-controlled trial (2005) Eur Urol, 48 (4), pp. 650-655; \n\nScheepens, W.A., Van Koeveringe, G.A., De Bie, R.A., Urodynamic results of sacral neuromodulation correlate with subjective improvement in patients with an overactive bladder (2003) Eur Urol, 43 (3), pp. 282-287; \n\nJanknegt, R.A., Hassouna, M.M., Siegel, S.W., Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence (2001) Eur Urol, 39 (1), pp. 101-106", "hasCitationDuplums" : false, "userChangeableUntil" : "2017-06-01T05:18:20.000+0000", "publishDate" : "2014-01-27T13:31:22.000+0000", "directInstitutesForSort" : "", "ownerAuthorCount" : 4, "ownerInstituteCount" : 21, "directInstituteCount" : 0, "authorCount" : 3, "contributorCount" : 0, "hasQualityFactor" : false, "link" : "/api/publication/23616652", "label" : "Canda AE et al. Pharmacology of the lower urinary tract and management of overactive bladder. (2006) JOURNAL OF TURKISH-GERMAN GYNAECOLOGICAL ASSOCIATION 1309-0399 1309-0380 7 2 146-157", "template" : "